Jesteś tutaj

Spis publikacji M. Pisklak :


  1. M. Pisklak, F. Herold, R. Anulewicz-Ostrowska, I. Wawer; Structural studies of 4-aryloctahydro-pyrido[1,2-c] pyrimidine derivatives Journal of Molecular Structure , 605 (2002) 85
  2. M. Pisklak, D. Maciejewska, F. Herold, I. Wawer; Solid state structure of coumarin anticoagulants: warfarin and sintrom 13C CPMAS NMR and GIAO DFT calculations Journal of Molecular Structure , 649 (2003) 169
  3. M. Pisklak, J. Kossakowski, M. Perliński, I. Wawer; 1H, 13C NMR studies and GIAO/DFT calculations of substituted n_(4-aryl-1-piperazynylbutyl) derivatives new analogues of buspirone Journal of Molecular Structure , 698 (2004) 93
  4. I. Wawer, D.M. Pisklak, Z. Chilmończyk; 1H 13C 15N NMR analysis of sildenafil base and citrate (Viagra) in solution, solid state and pharmaceutical dosage forms Journal of Biomedical and Pharmaceutical Analysis, 38 (2005) 865
  5. I. Wawer, D.M. Pisklak, K. Paradowska; NMR ciała stałego - zastosowanie w farmacji i diagnostyce medycznej; Wiadomości Chemiczne, 59 (2005) 121-137
  6. M. A. Dobrowolski, M. K. Cyrański, M. Pisklak, I. Wawer , D. Matosiuk: Structural studies of 1-aryl-2-aminoimidazolinum bromides: focus on tautomer preferencje of the 2-aminoimidazoline moiety In the solid state; Pol. J. Chem. 87 (2007) 1037- 1048
  7. A. Siwek, I. Wawrzycka-Gorczyca, M. Wujec, M.Pitucha, M. Dobosz, D. M. Pisklak Synthesis of new 1,2,4 triazoles. Annals of Polish Chemical Society 2007.
  8. M. Wujec, M. Pisklak, M. Pitucha, M. Dobosz, A.Siwek The reactions of hydrazide 4-nitroimidazol-1-yl acetic acid with isothiocyanates . Annals of Polish Chemical Society 2007
  9. M. Pisklak, M. Król, F. Herold, I. Wolska , I. Wawer Structural studies of pyrido [1,2-c]pyrimidine derivatives by 13C CP MAS NMR, X-ray diffraction and GIAO/DFT calculations. J.Mol.Struct  892 (2008)  325
  10. K. Paradowska, M. Wolniak, M.  Pisklak, J. Glinski, M. Davey,H.; 13C, 15N CPMAS NMR and GIAO DFT calculations of stereoisomeric oxindole alkaloids from Cat's Claw (Uncaria tomentosa) Solid State NMR  34 (2008) 2002
  11. R. Marszałek, M. Pisklak, D. Horsztyński, I. Wawer 1H, 13C, and 31P NMR studies of lyophilized brain tumours Solid State NMR 37 (2010) 21
  12. R. Marszałek, M. Pisklak, W. Jankowski, J. Łukaszkiwicz, D. Holsztyński, I. Wawer  NMR and gas chromatography studies of lyophilized human brain tumours Acta Polon. Pharm. 67 (20101) 129
  13. Zielińska-Pisklak, M.A., Pisklak, D.M., Wawer, I.  1H and 13C NMR characteristics of β-blockers Magnetic Resonance in Chemistry 49 (2011) 284 
  14. Gubica, T., Stpień, D.K., Ostrowski, A., Pisklak, D.M., Temeriusz, A., Głowacka, E., Paradowska, K., Cyrański, M.K. Crystal and molecular structure of nitrophenyl 2,3,4-tri-O-acetyl-β-d- xylopyranosides  Journal of Molecular Structure 1007 (2012)  227 
  15. Zielińska-Pisklak, M., Pisklak, D.M., Wawer, I. Application of 13C CPMAS NMR for qualitative and quantitative characterization of carvedilol and its commercial formulations Journal of Pharmaceutical Sciences 101 (2012). 1763
  16. Pisklak, D.M., Szeleszczuk, L., Wawer, I. 1H and 13C magic-angle spinning nuclear magnetic resonance studies of the chicken eggshell Journal of Agricultural and Food Chemistry 60 (2012) 12254
  17. Gubica, T., Stȩpień, D.K., Pisklak, D.M., Ostrowski, A., Cyrański, M.K. Single-crystal and powder X-ray diffraction, 13C CP/MAS NMR, and DFT-GIAO calculations of methyl 3,4,6-tri-O-acetyl-2-O-(2,3,4,6-tetra-O-acetyl- β-d-galactopyranosyl)-α-d-glucopyranoside and methyl 2,4,6-tri-O-acetyl-3-O-(2,3,4,6-tetra-O-acetyl-β-d-galactopyranosyl) -α-d-glucopyranoside Journal of Molecular Structure 1036 (2013) 407  
  18. Gubica, T., Bukowicki, J., Stȩpień, D.K., Ostrowski, A., Pisklak, D.M., Cyrański, M.K. Solid-state structure of methyl 2,4,6-tri-O-acetyl-3-O-(2,3,4,6-tetra-O- acetyl-β-d-glucopyranosyl)-β-d-galactopyranoside and methyl 3,4,6-tri-O-acetyl-2-O-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl) -β-d-galactopyranoside Journal of Molecular Structure 1037 (2013). 49  
  19. Pisklak, D.M., Zielińska-Pisklak, M., Szeleszczuk, L., Wawer, I. 13C cross-polarization magic-angle spinning nuclear magnetic resonance analysis of the solid drug forms with low concentration of an active ingredient-propranolol case Journal of Pharmaceutical and Biomedical Analysis, 93  (2014) 68
  20. Marinov M., Stoyanov N., Ugrinov A., Angelova S., Wawer I., Pisklak M., Enchev V.. Solid-state structures of 2-(4-hydroxyphenyl)-Substituted phenalene-1,3-dione and indan-1,3-dione; Journal of Structural Chemistry. 55 (2014) 446.
  21. Pindelska, E., Sokal, A., Szeleszczuk, L., Pisklak, D. M., Kolodziejski, W. Solid-state NMR studies of theophylline co-crystals with dicarboxylic acids. Journal of Pharmaceutical and Biomedical Analysis, 100 (2014) 322
  22. Gubica, T., Szeleszczuk, Ł., Pisklak, D. M., Stępień, D. K., Cyrański, M. K., Kańska, M. Reliable evaluation of molecular structure of methyl 3-O-nitro-α-d-glucopyranoside and its intermediates by means of solid-state NMR spectroscopy and DFT optimization in the absence of appropriate crystallographic data. Tetrahedron,  70 (2014) 1910.
  23. Szeleszczuk, L., Pisklak, D. M., Kuras, M., Wawer, I. In vitro dissolution of calcium carbonate from the chicken eggshell: on the study of calcium bioavailability. International Journal of Food Properties, 18 (2015) 2791.
  24. Pindelska, E., Szeleszczuk, L., Pisklak, D. M., Mazurek, A., Kolodziejski, W. Solid-state NMR as an effective method of polymorphic analysis: solid dosage forms of clopidogrel hydrogensulfate. Journal of Pharmaceutical Sciences, 104 (2015) 106.
  25. Pindelska, E., Szeleszczuk, L., Pisklak, D. M., Majka, Z., Kolodziejski, W. Crystal structures of tiotropium bromide and its monohydrate in view of combined solid-state NMR and GIPAW studies. Journal of Pharmaceutical Sciences, ,  104 (2015) 2285.